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Abstract
Background: Epileptic seizures are associated with an immune response in the brain. However, it is not known
whether it can extend to remote areas of the brain, such as the eyes. Hence, we investigated whether epileptic
seizures induce inflammation in the retina.
Methods: Adult rats underwent electrically induced temporal status epilepticus, and the eyes were studied 6 h, 1,
and 7 weeks later with biochemical and immunohistochemical analyses. An additional group of animals received
CX3CR1 antibody intracerebroventricularly for 6 weeks after status epilepticus.
Results: Biochemical analyses and immunohistochemistry revealed no increased cell death and unaltered
expression of several immune-related cytokines and chemokines as well as no microglial activation, 6 h
post-status epilepticus compared to non-stimulated controls. At 1 week, again, retinal cytoarchitecture appeared
normal and there was no cell death or micro- or macroglial reaction, apart from a small decrease in interleukin-10.
However, at 7 weeks, even if the cytoarchitecture remained normal and no ongoing cell death was detected, the
numbers of microglia were increased ipsi- and contralateral to the epileptic focus. The microglia remained within the
synaptic layers but often in clusters and with more processes extending into the outer nuclear layer. Morphological
analyses revealed a decrease in surveying and an increase in activated microglia. In addition, increased levels of the
chemokine KC/GRO and cytokine interleukin-1β were found. Furthermore, macroglial activation was noted in the inner
retina. No alterations in numbers of phagocytic cells, infiltrating macrophages, or vascular pericytes were observed.
Post-synaptic density-95 cluster intensity was reduced in the outer nuclear layer, reflecting seizure-induced synaptic
changes without disrupted cytoarchitecture in areas with increased microglial activation. The retinal gliosis was
decreased by a CX3CR1 immune modulation known to reduce gliosis within epileptic foci, suggesting a common
immunological reaction.
Conclusions: Our results are the first evidence that epileptic seizures induce an immune response in the retina. It has a
potential to become a novel non-invasive tool for detecting brain inflammation through the eyes.
Keywords: Inflammation, Microglia, Astrocytes, Epilepsy, Retina, Brain
* Correspondence: Christine.Ekdahl_Clementson@med.lu.se
Matilda Ahl, Una Avdic, Ulrica Englund Johansson, and Christine T Ekdahl
shared first and last authorship, respectively.
1Inflammation and Stem Cell Therapy Group, Division of Clinical
Neurophysiology, Lund University, BMC A11, Sölvegatan 17, SE-221 84 Lund,
Sweden
2Lund Epilepsy Center, Lund University, SE-221 85 Lund, Sweden
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ahl et al. Journal of Neuroinflammation  (2016) 13:155 
DOI 10.1186/s12974-016-0618-3
Background
Epilepsy is a neurological disorder characterized by spon-
taneous seizures, affecting almost 1 % of the population
worldwide [1]. An epileptic seizure is an abrupt abnormal
synchronized activity affecting the entire—or parts, of the
brain. When a seizure engages the entire brain, called a
generalized seizure, the patients experience disturbed con-
sciousness and often tonic-clonic muscle movements. Sei-
zures initiated in parts of the brain are named focal
seizures and may induce a plethora of symptoms often
correlated to the function or lack of function of that par-
ticular brain region. The etiology of epilepsy varies. It may
arise due to a brain infection, trauma, ischemia, tumor,
neurodegenerative disease, or genetic predisposition. A
large proportion is cryptogenic. Almost 40 % of epilepsy
patients are resistant to current anti-epileptic therapy,
which makes investigation of new therapeutic targets and
biomarkers for patient stratification warranted.
Pathological hallmarks in the brain associated with
epilepsy include imbalance in synaptic transmission,
neuronal damage, and an exaggerated immune response
[2–6]. During the acute innate immune response in the
brain following seizures, microglia release pro- and anti-
inflammatory mediators [7], undergo phenotypic changes,
and migrate towards the epileptic foci where they
phagocytize cell debris [8, 9]. Moreover, astrocytes change
their activity state and exhibit disturbed buffering capacity
of ions and glutamate uptake [10]. In addition to the in-
nate immune reaction, seizures may cause blood-brain
barrier dysfunction and activation of vascular-associated
and blood-derived immune cells [5]. Hitherto, a seizure-
induced immune response has primarily been described
within the epileptic foci of the brain, such as in hippocam-
pal sclerosis in medial temporal lobe epilepsy, the most
common form of epilepsy [4]. However, recent findings
support the idea that seizures may be viewed as a disturb-
ance of entire brain networks, including subcortical nodes
for seizure propagation [11]. More remote areas of the
brain, such as the retina, have not yet been investigated at
all. Recently, we reported microglial activation in both
cortical and subcortical brain areas even before behavioral
seizures had developed in a genetic mouse model of epi-
lepsy [12]. Therefore, the relationship between brain in-
flammation and epileptogenesis may also be further
understood by studying the immune response in remote
areas to the epileptic foci that are not known to either
generate or propagate seizures.
In the present study, we therefore decided to explore
whether a post-seizure immune response can extend be-
yond an epileptic focus within the temporal lobes and,
hence, be detected as far as the retina of adult rats. The
retina lines the back of the eyeball and constitutes a re-
mote extension of the brain, so far not considered to ex-
hibit seizure-induced pathology. It is a light-sensitive
neural structure with several layers of strictly intercon-
nected neurons [13]. The innate and adaptive immune
response of the retina involves, similar to other brain re-
gions, the activation of microglia and macroglial cells
(i.e., astrocytes and Müller cells), vascular pericytes, and
leucocytes that cross the blood-retina barrier (BRB) [14–
16]. Since the retinal immune response is more
accessible than the cerebral immune response for non-
invasive investigations, it may become an attractive bio-
marker of brain inflammation if it reflects the immune
response in the rest of the brain. Here, we evaluated mi-
cro- and macroglial activation, leukocyte infiltration, and
number of vascular pericytes in the retina, acutely and
late after electrically induced temporal status epilepticus.
We also investigated whether a seizure-induced retinal
immune response may be modulated by intracerebro-




Adult male Sprague Dawley rats (n = 78) weighing be-
tween 200 and 250 g were procured from Charles River
(Germany). The animals were housed in a 12-h light/
dark cycle with ad libitum food and water. All experi-
mental procedures followed the guidelines set by the
Malmö-Lund Ethical Committee in Sweden for the use
and care of laboratory animals, and the ARVO statement
for the use of animals in ophthalmic and vision research.
Group assignment
Animals were divided into three survival groups follow-
ing electrically induced temporal status epilepticus (SE)
and corresponding non-stimulated controls (NSC): 6 h
(SE n = 4 and NSC n = 5 were perfused, SE n = 4 and
NSC n = 4 were homogenized), 1 week (SE n = 9 and
NSC n = 8 were perfused, SE n = 6 and NSC n = 6 were
homogenized), and 7 weeks (SE n = 6, SE + CX3CR1
antibody n = 7 and NSC + saline infusion n = 9 were per-
fused SE n = 5 and NSC n = 5 were homogenized).
Surgeries, drug infusions, and electrically induced
temporal status epilepticus
Animals were anesthetized with 2 % isofluorane and im-
planted with a bipolar-insulated stainless steel electrode
(Plastics One, Roanoke, VA) into the right ventral CA1/
CA3 region of the hippocampus (coordinates 4.8 mm
posterior and 5.2 mm lateral from the bregma and
6.3 mm ventral from the dura, tooth bar set at −3.0 mm)
for stimulation and recording. A unipolar electrode was
placed between the skull and adjacent muscle to serve as
ground electrode. In addition, a subset of animals were
implanted with intracerebroventricular cannulae (Brain
Infusion Kit 1, ALZET, USA): coordinates 1.0 mm
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posterior and 1.5 mm lateral to the bregma and 3.5 mm
ventral to the flat skull position (with the bregma as ref-
erence) ipsilateral to the electrode placement for con-
tinuous saline or CX3CR1 antibody infusion (20 μg/ml;
Abcam, UK) from a subcutaneously implanted osmotic
pump (ALZET) during either 1 week after SE or during
6 weeks starting 1 week after SE. Following a week of re-
covery after surgery, rats were subjected to electrically
induced temporal SE according to previously described
protocol [17]. Electrode- and cannulae-implanted non-
stimulated rats served as controls (NSC). Only rats that
displayed self-sustained ictal electroencephalographic
(EEG) activity for 2 h (Fig. 1) in the temporal lobe and
mainly partial seizure semiology according to previous
description [17], e.g., oralfacial twitches, nodding, drool-
ing, and unilateral forelimb clonus, according to Racine’s
scale, were included in this study [18]. Behavioral symp-
toms and ictal EEG activity were completely interrupted
after 2 h of self-sustained SE by the administration of
pentobarbital (65 mg/kg, intraperitoneal injection)
(Fig. 1a).
Tissue preparation
For biochemical analyses, rats were decapitated and the
eyes, excluding the lenses, were immediately collected,
frozen on dry ice, and stored in −80 °C. For immunohis-
tochemistry, rats were perfused with ice-cold 0.9 % sa-
line and paraformaldehyde (PFA) (4 % in 0.1 M
phosphate-buffered saline (PBS), pH 7.4). The eyes were
enucleated and post-fixed in PFA for 4 h, rinsed in
PBS, incubated in 10 % sucrose (16 h) and 25 % su-
crose (16 h), consecutively embedded in a Yazulla
medium (30 % egg albumin, 3 % gelatin), and finally
cut in 20 μm-thick sagittal cryosections (Microm HM
560, US) and stored at −20 °C.
Multiplex enzyme-linked immunosorbent assay (ELISA)
Samples were homogenized on ice in buffer (pH 7.6)
containing (in millimolars) 50.0 Tris-HCl, 150 NaCl, 5.0
CaCl2, 0.02 % NaN3, and 1 % Triton X-100, and then
centrifuged at 17,000g for 30 min at 4 °C. The super-
natant was collected into a microcentrifuge tube, where
the total protein concentration was determined by BCA
protein assay (BCA, Pierce, Rockford, IL) as per manu-
facturer’s instructions. Levels of interleukin (IL)-1β,
tumor necrosis factor (TNF)-α, interferon (IFN)-γ, IL-4,
IL-5, IL-6, IL-10, IL-13, and keratinocyte chemoattract-
ant/growth-related oncogene (KC/GRO) were measured
by sandwich immunoassay methods using commercially
available electrochemiluminescent detection system,
plates, and reagents (V-PLEX Proinflammatory Panel 2
(rat) kit, Meso Scale Discovery (MSD), Gaithersburg,
MD, USA) as per manufacturer’s instructions with minor
modifications. Briefly, 100 μg (50 μl) of the protein sample
was loaded per well in the MSD plate. The samples were
incubated overnight at 4 °C with shaking. For each assay,
samples were analyzed in duplicates and compared with
known concentrations of protein standards. Plates were
analyzed using the SECTOR Imager 2400.
Fig. 1 Electroencephalographic recordings from intrahippocampal electrodes before, during, and after electrically induced temporal status epilepticus
(SE). a Representative baseline activity in rats before stimulations (top), high-frequency epileptiform activity during the 2 h of self-sustained SE (middle),
and baseline activity after SE was terminated with pentobarbital injection (bottom). b Pie chart showing the relative distribution of different seizure
semiology during the 2-h SE period. The semiology is based on the Racine’s scale [18], where stages 0–2 and 3–5 represent partial and generalized
seizure semiology, respectively. Each segment depicts the mean percentage of time spent exhibiting the behavior
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Western blot analysis
Western blot analyses were performed as previously
described [19]. The following primary Abs were used:
mouse monoclonal anti-β actin (1:10,000; Sigma-Aldrich,
MO, US), rabbit monoclonal anti-glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (1:2000; Cell Signaling
Technologies, CA, USA), rabbit polyclonal anti-CX3CR1
(1:500; Abcam, Cambridge, UK), and mouse monoclonal
anti-postsynaptic density-95 (PSD-95) (1:200, Abcam).
Secondary Abs used were either horseradish peroxidase-
conjugated anti-mouse or anti-rabbit (both 1:5000;
Sigma-Aldrich). Band intensities were quantified using
ImageJ software (NIH, USA), and β-actin or GAPDH
was used as a loading control.
Fluoro-Jade staining
Sections were washed with potassium PBS, hydrated,
and pretreated with 0.06 % potassium permanganate for
15 min, rinsed with distilled water, and treated with
0.001 % Fluoro-Jade (Histo-Chem, Jefferson, AR, USA)
for 30 min. They were then washed with distilled water,
dehydrated by treatment with ethanol and xylene, and
coverslipped with PERTEX mounting medium.
Immunohistochemistry and hematoxylin-eosin staining
Immunohistochemistry was performed as previously de-
scribed [20]. The following primary Abs were used: rabbit
polyclonal anti-Iba1 (1:1000; Wako, Japan), mouse anti-rat
CD68/ED1 (1:200; AbD Serotec, NC, USA), rabbit anti-
CD-45 (1:100; Santa Cruz Biotechnology, TX, USA),
mouse anti-neuron glial antigen 2 (NG2) (1:200; Millipore,
MA, USA), mouse anti-glial fibrillary acidic protein
(GFAP) (1:400; Sigma-Aldrich), goat anti-Iba1 (1:250;
AbD Serotec), mouse anti-PSD-95 (1:500; Abcam), rabbit
anti- IL-6 (1:400; Abcam), rabbit anti-IL-4 (1:100, Abcam),
and goat anti-IL-1β (1:100; Santa Cruz Biotechnology).
Sections were incubated with appropriate primary Abs
overnight at 4 °C and secondary antibody for 1 h at room
temperature. For each immunohistochemical assessment,
some eye sections went through the entire protocol with-
out primary Abs incubation to serve as the negative
controls. The following secondary Abs were used: Cy3-
conjugated donkey anti-mouse/rabbit/goat (1:200; Jackson
ImmunoResearch, UK), Alexa-488 conjugated donkey
anti-mouse/rabbit (1:200; Invitrogen, NY, USA), and Cy2-
conjugated donkey anti-rabbit (1:200; Jackson ImmunoRe-
search). For counterstaining of nuclei, the sections were
coverslipped using 496-diamidino-2-phenylindole (DAPI)-
containing VECTASHIELD mounting medium (Vector
Laboratories, Burlingame, CA, USA) and stored in −20 °C
until cell quantification. For gross morphological analyses,
sections were stained with hematoxylin-eosin (Htx-eosin)
for 1 min, dehydrated, and coverslipped using PERTEX
mounting medium (HistoLab, Sweden).
Morphological analyses, cell countings, and intensity
measurements
First, an overall gross morphological analysis of retinal
lamination was performed throughout the entire retina
using light microscopy, in four sections from ipsi- and
contralateral eyes, respectively. Second, detailed analyses
were performed with regard to nuclear layer morphology
using the ranking system 0–2 (0 = normal nuclear layer
morphology and the presence of 0–10 pyknotic (shrunken)
nuclei; 1 = islands of disseminated nuclear layers without
nuclei (typically the size of 1–2 cells) and 11–20 pyknotic
nuclei; 2 = completely disseminated nuclear layers and >20
pyknotic nuclei) as described previously [21].
Quantifications of Iba1, ED1, CD45, and NG2-positive
cells were performed in 8–12 regions of interest (ROIs)
within 4–6 sections/eye, located in the peripheral retina,
approximately 500 μm from the ora serrata (the junction
between the retina and the ciliary body), using an Olym-
pus BX61 epifluorescence microscope. The data is pre-
sented as the number of cells per ROI, which constituted
an area of 16 × 104 μm2 in the Iba1, ED1, NG2, and CD45
stainings. Each ROI included the following retinal layers:
inner limiting membrane (ILM), nerve fiber layer (NFL),
ganglion cell layer (GCL), inner plexiform layer (IPL),
inner nuclear layer (INL), outer plexiform layer (OPL),
and outer nuclear layer (ONL) (Fig. 2). For morphological
analyses of microglia phenotypes in the same regions, a
total number of 240 (6 h) and 120 (1 and 7 weeks) Iba1+
cells were analyzed per eye for three different subtypes:
ramified (small soma and extensive dendritic tree), inter-
mediate (larger soma and less extensive dendritic tree),
and round/amoeboid (no processes), according to previ-
ously described definitions [12, 19]. The relative occur-
rence of each subtype was expressed as the mean
percentage of Iba1+ cells per eye. The morphological as-
sessments were further confirmed by quantifications of
the length of the most extended process per Iba1+ cell,
and Iba1+ cell soma diameter in ten Iba1+ cells per retina,
from the same ROIs in the peripheral ipsilateral retina as
the morphological evaluations, using Cell Sense Olympus
software and Olympus BX61 epifluorescence microscope.
Semi-quantitative analysis of GFAP expression was
performed in 12 representative images from four sections/
eye, using Olympus BX61 epifluorescence microscope.
The density of GFAP+ radial Müller cell processes was
graded according to a 0–5 scale in IPL (0 = none, 1 = 1–5,
2 = 6–10, 3 = 11–20, 4 = 21–50, 5 = >50 processes) and a
0–3 scale in INL +OPL and ONL, respectively (0 = none,
1 = 1–5, 2 = 6–10, 3 = >10 processes). In addition, number
of GFAP+ retinal astrocytes was manually quantified
in 12 representative images of the inner retina from
four sections/eye.
Intensity measurements of GFAP expression in the
GCL, NFL, and ILM were performed in fluorescence
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images from 12 sections/eye (each image corresponding
to 13 × 103 μm2), using an Olympus BX61 epifluores-
cence microscope (Leica, Germany). Intensity measure-
ments of PSD-95 expression in IPL, INL, OPL, and
ONL, respectively, were performed with confocal laser
scanning microscope (Zeiss, Germany) with a 561-nm
excitation filter, ×63 oil-immersion objective, and ×5
zoom. Intensity measurements of IL-6, IL-4, and IL-1β
expression in IPL, INL, OPL, and ONL, respectively,
were carried out with a 488-nm and 561-nm excitation
filter, ×40 oil-immersion objective, and ×5 digital zoom.
Images were taken from three representative areas from
each animal. Each image was acquired in a z-stack at
an interval of 0.2 μm, on average 50 slices per z-stack.
The images were analyzed in ImageJ software and the
brightness and contrast corrected and noise reduced
using the built-in ImageJ functions. Background inten-
sity was measured in every image and subsequently
subtracted from the mean gray value from each image
in order to obtain a background-corrected mean gray
value per animal.
To ensure the lack of bias, all analyses were conducted
by an observer blind to the treatment conditions.
Statistics
Statistical analyses were performed with the unpaired Stu-
dent’s t test when comparing two groups, using GraphPad
Prism software, except for analyses of gross morphology
and grading of GFAP+ processes where Mann-Whitney’s
rank sum test for non-parametric variables was applied.
Microglial morphology was analyzed with two-way analysis
of variance (ANOVA) followed by a Bonferroni post hoc
test. Data are presented as means ± SEM, apart from gross
morphology and GFAP+ process evaluations, which are
presented as median ± range with upper quartile range. Dif-
ferences were considered statistically significant at p ≤ 0.05.
Results
Lack of acute changes in the expression of immune
mediators, glial activation, and cell death in the eyes after
temporal status epilepticus
We performed cytoarchitectural analyses of the eye tissue.
However, in the retina at the time point 6 h post-SE, no
obvious pathological signs were found at the gross cyto-
architectural level, when assessed using Htx-eosin staining
(Fig. 2a), with the retina showing well-defined and
homogenous nuclear and synaptic layers and nerve fiber
Fig. 2 Lack of changes in cytoarchitecture in the retina after temporal SE. No changes in cytoarchitecture or gross morphology were found in the
retina after SE. Representative photomicrographs representing the entire eye (a) and of gross morphology at 6 h (b), 1 week (c), and 7 weeks (d)
following SE and in non-stimulated control rats (NSC) in ipsi- and contralateral retina related to seizure origin. Arrow heads (d) depict islands of
disseminated GCL. Very few Flouro-Jade+ cells were found (e). NFL nerve fiber layer, GCL ganglion cell layer, IPL inner plexiform layer, INL inner
nuclear layer, OPL outer plexiform layer, ONL outer nuclear layer. Scale bars are 500 μm in (a) and 50 μm for (b), (c), (d) and (e)
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layer. Detailed morphological analysis of the retina re-
vealed no differences between SE and NSC group in the
ipsi- and contralateral eyes, with both retinas displaying
well-preserved nuclear layer morphology and no pyknotic
cells and disseminated GCL at 6 h (ipsilateral SE 0 u = 0
vs NSC 0 u = 0 and contralateral SE 0 u = 0 vs NSC 0 u =
0; Fig. 2b). Less than three Fluoro-Jade+ cells were
observed in total per animal in both SE and NSC groups
(Fig. 2e), which made statistical analyses inadequate. In
order to detect an acute immune response in the eye, we
first performed immunohistochemical evaluations of
number of Iba1+ cells and the morphology of the micro-
glia, including ramified, intermediate, and round/
amoeboid phenotypes. However, no differences in Iba1+
cell number (Fig. 3a) or microglial morphology (Fig. 3b)
could be detected. Seizure-induced microglial activation is
also associated with a more phagocytic profile [6] and we
therefore double-stained Iba1+ cells with the phagocytic
marker ED1. Though, the number of Iba1+/ED1+ cells was
too low to be adequately analyzed (rarely more than 1–2
cells per retina in both NSC and SE group).
Next, biochemical analyses of pro- and anti-
inflammatory mediators in the protein homogenates
from the eye tissue excluding the lens at 6 h following
SE were evaluated. At this time point, several immune
factors are upregulated in the epileptic focus of the
hippocampus (Avdic U, Ahl M, Ekdahl CT, unpublished
observation). However, even though the chemokine KC/
GRO, chemokine receptor CX3CR1, and the cytokines
IL-6, IL-5, and IL-1β were detectable in the eyes, the
levels were unaltered compared to the NSC group, both
ipsi- and contralateral to the epileptic focus (Fig. 3d, e).
Lack of subacute changes in the expression of immune
mediators, glial activation, and cell death in the eyes after
temporal status epilepticus
We next performed cytoarchitectural analyses of the eye
tissue 1 week post-SE. At this time point, neuronal ne-
crosis and apoptotic cell death are readily observed in
varying degree within temporal structures, including the
hippocampus [17, 22]. However, in the retina, again, no
obvious pathological signs were found at the gross cyto-
architectural level. Detailed morphological analysis of
the retina showed no differences between SE and NSC
group in the ipsi- and contralateral eyes, with both ret-
inas displaying well-preserved nuclear layer morphology
and only occasional pyknotic cells and disseminated
GCL (ipsilateral SE 0.25 u = 0.875 vs NSC 0.5 u = 0.5
and contralateral SE 0 u = 0.75 vs NSC 0.25 u = 0.458
score) (Fig. 2c). Less than three Fluoro-Jade+ cells per
animal were observed in both groups.
Furthermore, no differences in Iba1+ cell number
(Fig. 4a) or microglial morphology (Fig. 4b) could be
detected. The number of Iba1+/ED1+ cells was less than
Fig. 3 No changes in microglial activation or cytokine and chemokine protein expression in the eyes 6 h after temporal SE. No changes were
observed in number of Iba1+ cells (a) or in Iba1+ cell morphology (b) between NSC and SE. Representative Western blot and quantification of
CX3CR1 protein (~50 kDa) relative to NSC in the ipsilateral and contralateral eye 6 h post SE (c). Quantification of cytokine and chemokine protein
expression, using mesoscale multiplex ELISA, in ipsilateral (d) and contralateral (e) eye homogenates 6 h after SE showed no differences compared to
NSC. Data are presented as mean ± SEM, n = 5 NSC and n = 4 SE for WB and ELISA, n = 4 NSC and n = 4 SE for cell count and morphology.
*p ≤ 0.05, unpaired t test in (a) and (c–e) two-way ANOVA in (b)
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2–3 cells per retina in both groups. The expression of
immune mediators was unaltered, apart from a small
decrease in IL-10 in the ipsilateral eye (Fig. 4c, d).
Delayed glial activation in the retina after temporal status
epilepticus
We hypothesized that a seizure-induced tissue injury
may be delayed in the retina compared to other brain
structures and, therefore, we extended our analyses to a
later time point, i.e., 7 weeks after SE. Again, no changes
in retinal laminar organization or significant changes in
the cytoarchitecture (ipsilateral SE 1.0 u = 1 vs NSC 0.5
u = 0.75 and contralateral SE 0.25 u = 0.375 vs NSC
0.333 u = 0.50 score) could be detected (Fig. 2d). The
quantification of Fluoro-Jade+ cells in the retina never
exceeded three cells per eye.
The immune response in epileptic foci is often charac-
terized by a prominent activation of microglial cells,
which can be detected both acutely and chronically after
SE [6, 23]. In the retina of both the NSC and 7 weeks
post-SE group, the Iba1+ microglial cells were primarily
located in the synaptic layers (OPL and IPL) and the
GCL (Fig. 5a, b). The morphology of the microglia
included again ramified, intermediate, and round/
amoeboid phenotypes (Fig. 5c). Interestingly, the number
of Iba1+ cells was increased bilaterally (Fig. 5d), with a
few aberrant cell clusters in the INL and the occurrence
of processes in the ONL (Fig. 5b). Accordingly, the
morphology of the Iba1+ cells significantly changed. The
SE group showed a relative decrease in ramified and an
increase in round/amoeboid microglial phenotype with a
significant interaction between groups and morphology
in both the ipsi- and contralateral retina (Fig. 5e). The
morphological differences were further confirmed in a
subset of animals (n = 3 + 3, NSC and 7 weeks post-SE
group, respectively) with larger Iba1+ cell soma diameter
(SE 13.59 ± 0.71 vs NSC 9.57 ± 0.27 μm) and less ex-
tended processes per Iba1+ cell (SE 28.18 ± 2.11 vs NSC
38.78 ± 2.73 μm) in the ipsilateral retina of SE rats. Bio-
chemical analyses of eye homogenates showed increased
KC/GRO levels in the ipsilateral eye (Fig. 5f, g). Intensity
measurement of immonohistochemical stainings for
three pro- and anti-inflammatory markers, showed re-
gional alterations in Il-1β levels, with an increase in IPL
(Fig. 5h) in the ipsilateral eye, while the intensity of IL-
6 or IL-4 remained unaltered (Fig. 5i, j). No changes in
Il-1β, IL-6, and IL-4 intensity could be detected in
other retinal layers including INL, OPL, and ONL (data
not shown).
Less than 1–2 single-labeled ED1+ cells and Iba1+/ED1
+ cells per retina were detected at 7 weeks post-SE (data
not shown). The cells were uniformly distributed among
the retinal layers (Fig. 5k). In order to evaluate a possible
systemic contribution of leukocytes to the immune re-
sponse in the retina after SE, numbers of CD45+ cells
were evaluated at 7 weeks, but again, very low cell num-
bers were found with no differences between the two
groups (ipsilateral SE 0.38 ± 0.13 vs NSC 0.97 ± 0.22,
contralateral SE 0.88 ± 0.38 vs NSC 1.53 ± 0.34). At
both 1 and 7 weeks, CD45+ cells were primarily located
in the subretinal layers, not overlapping with the Iba1
staining (Fig. 5l).
In an attempt to define whether the immune response
in the retina was associated with a subtle microvascular
disturbance, we also analyzed the numbers of vascular
NG2-expressing pericytes [16]. NG2+ cells were found in
the same retinal layers as the Iba1+ cells, but their ex-
pressions did not overlap (Fig. 5m). Often, the NG2+
cells were aligned in a cluster of 2–3 cells, as if embra-
cing a microvessel (Fig. 5m inset). However, the cell
numbers did not differ between SE and NSC group nei-
ther 1 nor 7 weeks post-SE (1 week ipsilateral SE 9.64 ±
0.40 vs NSC 8.76 ± 0.62 and contralateral SE 8.67 ± 0.29
vs NSC 9.60 ± 0.51; 7 weeks ipsilateral SE 7.97 ± 0.64 vs
NSC 8.38 ± 0.31, contralateral SE 7.47 ± 0.51 vs NSC
8.16 ± 0.76).
Fig. 4 No changes in microglial activation or cytokine and chemokine protein expression in the eyes 1 week after temporal SE. Number of Iba1+ cells
(a) and the Iba1+ cells morphology (b) did not differ between NSC and SE. Biochemical analyses of cytokine and chemokine protein expression in the
ipsilateral (c) and contralateral (d) eye detected a small decrease in IL-10 in the ipsilateral eye. Data are presented as mean ± SEM, n = 6 NSC and n = 6
SE for ELISA and n = 8 NSC and n = 9 SE for cell count and morphology. *p≤ 0.05, unpaired t test in (a) and (c–d), two-way ANOVA in (b)
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Fig. 5 Delayed microglial activation in the retina 7 weeks after temporal SE. Representative confocal photomicrographs of microglial activation
in non-stimulated controls NSC (a) and 7 weeks after SE (b). Arrow heads in (a) and (b) depict Iba1+ cells in IPL and GCL. Arrows in B mark Iba1+
processes in the ONL. Representative images of different Iba1+ cell morphologies, including ramified (RAM), intermediate (INT), and round/
amoeboid (R/A) (c). Note the elongated cell soma and thicker proximal processes in INT compared the RAM cells. Quantification of numbers of
Iba1+ cells in the ipsi- and contralateral retina 7 weeks following SE compared to NSC showed an increase after SE (d). Quantification of the
relative percentage of microglia with the three different morphologies revealed a relative reduction in ramified and an increase in amoeboid
morphology in the SE group (e). Biochemical analysis detected a SE-induced increase in chemokine KC/GRO levels in ipsilateral retina (f), but
no changes in the contralateral eye (g). Representative pictures and intensity measurements in the IPL of cytokine IL-1β (h), IL-6 (i), and IL-4 (j)
immune staining showed increased levels of IL-1β only. Confocal images of Iba1 and ED1 immunostaining of the retina (left) and orthogonal
projection of an Iba1+ ED1+ cell (right) (k), Iba1 and CD45 immunostaining of the retina (l), and Iba1 and NG2 immunostaining of the retina with
NG2+ cells in higher magnification in inset (m). Data are presented as means ± SEM, n = 5 NSC and n = 5 SE for ELISA, n = 9 NSC and n = 6 SE for
cell quantification and evaluation. *p≤ 0.05 un-paired t test in (d) and (i–j), 2-way ANOVA in (e). Scale bars are 500 μm for (a) and (b), 10 μm for
(c) 5 μm for (h-j), 25 μm for (k–m), and insets 3 μm for (k) and 5 μm for (m)
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Apart from microglial activation, seizure-induced glio-
sis in the brain is also associated with a strong astrocytic
reaction, which is readily evaluated by the typical upreg-
ulation of GFAP [24, 25]. In the retina, Müller cells and
retinal astrocytes, together referred to as macroglia, are
responsible for injury-induced gliosis [26]. In NSC rats
at 7 weeks post-SE, only weakly labeled GFAP+ Müller
cell end feet/processes and astrocytes were found in
ILM and GCL (Fig. 6a, arrows). We graded the number
of GFAP+ Müller cell processes in the IPL, INL +OPL,
and ONL, respectively, and found extensive GFAP+
staining in the ILM and GCL and, occasionally, also in
the Müller cell end feet in the outer limiting membrane
outside the ONL. It was significantly increased in the
IPL contralaterally and there was a trend towards an in-
crease (p = 0.07) ipsilaterally to the epileptic focus
(Fig. 6a, b). The increase was also significant in the INL
and OPL on the contralateral side (ipsilateral SE 0 u =
1.56 vs NSC 0 u = 0, contralateral SE 0.13 u = 1.04 vs
NSC 0 u = 0). No differences were found in the ONL
(data not shown). The high variation in glial activation
in the SE group did not correlate to SE severity (total
time a rat exhibited generalized tonic-clonic seizures
during the 2 h of SE (regression analysis p = 0.7, r-value =
−0.12), as previously seen for microglial activation in the
brain [6]). This increase in number of GFAP+ processes
at 7 weeks was not evident at either 6 h or 1 week post-
SE (data not shown). However, at these acute and sub-
acute time points, high variation within both the NSC
and SE group made statistical analyses uncertain. At 6 h
post-SE, we even detected a small decrease in GFAP+
processes in the IPL contralateral to the epileptic focus
(ipsilateral SE 1.083 u = 1.21 vs NSC 1.694 u = 2.93,
contralateral SE 1 u = 1.04 vs NSC 1.74 u = 3.48) com-
pared to NSC. In addition, the overall intensity of GFAP
immunostaining was measured in the ILM, NFL, and
GCL but showed no differences either 6 h, 1, or 7 weeks
post-SE compared to NSC group (6 h ipsilateral SE 19.6
± 3.3 vs NSC 16.7 ± 2.7, contralateral SE 23.5 ± 2.7 vs
NSC 21.5 ± 1.0; 1 week ipsilateral SE 26.94 ± 2.10 vs NSC
24.31 ± 2.05, contralateral SE 24.62 ± 2.70 vs NSC 25.48 ±
2.06; 7 weeks ipsilateral SE 18.61 ± 1.53 vs NSC 19.09 ±
0.89, contralateral SE 19.93 ± 1.62 vs NSC 18.73 ± 0.60).
At all time points, in both the NSC and SE group, small
cell bodies of GFAP+ retinal astrocytes with relatively thin
processes were found also in the IPL (Fig. 6a, arrow
heads). However, the number of GFAP+ retinal astrocytes
in the IPL did not differ at 7 weeks (ipsilateral SE 0.14 ±
0.06 vs NSC 0.07 ± 0.06, contralateral SE 0.03 ± 0.02 vs
NSC 0.05 ± 0.03).
Altered synaptic protein expression in the retina after
temporal status epilepticus
Even if the epileptic seizures did not induce a prominent
cell loss with changes in the cytoarchitecture of the ret-
ina, it may still induce a more subtle imbalance in syn-
aptic transmission between neurons. The activation of
micro- and macroglia may indicate such an ongoing syn-
aptic/neuronal dysfunction. We have previously shown
that levels of the scaffolding protein PSD-95, expressed
primarily in excitatory synapses, may change due to an
immune response in the brain [20]. Here, we measured
the protein levels of PSD-95 in the eye 6 h post-SE but
found no differences (ipsilateral SE 135.40 ± 44.07 n = 3
vs NSC 100.00 ± 50.44 n = 4, contralateral SE 172.20 ±
57.34 n = 3 vs NSC 100.00 ± 27.92 n = 5). However, in-
tensity measurements of PSD-95 clusters 1 and 7 weeks
post-SE in the different retinal layers revealed a small
decrease in the ONL at 7 weeks in the retina ipsilateral
to the epileptic focus (Fig. 7a–c).
Fig. 6 Delayed macroglial activation in the retina after temporal SE. Representative photomicrographs of GFAP expression on macroglia in the
retina of NSC (a) and 7 weeks post-SE (b). The extension of GFAP+ processes and their end feet in different retinal layers are visualized in (b).
Arrows depict GFAP+ end feet of Müller cells in ILM and arrow heads mark GFAP+ retinal astrocytes. Quantification of GFAP+ Müller cell
processes in the IPL showed increased expression after SE (c). Data are presented as median range with upper quartile range, n = 9 NSC and
n = 6 SE group (c). *p≤ 0.05 Mann-Whitney’s rank sum test. Scale bar is 50 μm for (a) and (b)
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Intracerebroventricular CX3CR1 antibody infusion
decreases micro- and macroglial activation in the retina
after temporal status epilepticus
In order to evaluate possible similarities between the im-
mune reaction in the retina and within the epileptic
focus, an antibody (Ab) against the chemokine receptor
CX3CR1 was infused intracerebroventricularly during
6 weeks starting 1 week after SE. The CX3CR1 is
expressed on the microglia in the brain, including the
retina, and can be upregulated both before and after sei-
zures. Its ligand, fractalkine, is expressed by neurons and
glial cells [27, 28]. Recently, we showed that inhibition
of CX3CR1 with the same CX3CR1 Ab decreases micro-
glial activation within the temporal epileptic foci [19].
Then, micro- and macroglial activation was evaluated in
the retina 7 weeks post-SE. We observed an almost 25 %
significant decrease in the number of Iba1+ cells in the
contralateral retina in the SE group treated with
CX3CR1 Ab, compared to the SE group with saline infu-
sion, and there was a trend towards a decrease (p = 0.07)
in the ipsilateral retina (Fig. 8a–c). The morphology of
Iba1+ cells was also changed with a higher percentage of
ramified and less intermediate and round phenotypes in
the CX3CR1 Ab-treated SE group on both the ipsi- and
contralateral side (Fig. 8d). In addition, the number of
GFAP+ Müller cell processes was decreased in the
CX3CR1 Ab-treated group, with fewer processes in the
IPL in both ipsilateral and contralateral retina (Fig. 8e–g).
However, the decrease did not reach significance in the
INL and OPL on either sides (data not shown). The de-
crease in the IPL was not due to the differences in seizure
severity during the SE (data not shown).
Discussion
Here, we provide the first evidence that epileptic seizures
arising within the temporal lobes of the adult rat brain
lead to glial activation in the retina. The activation in-
cludes both micro- and macroglia and is delayed in the
retina compared to the epileptic focus. The seizures origi-
nated from one hemisphere, but the retinal glial activation
occurred both ipsi- and contralaterally. Furthermore, we
show that the seizure-induced retinal glial activation can
be significantly reduced with intracerebroventricular
infusion of the same CX3CR1Ab as we have previously
demonstrated to reduce microglial activation within the
epileptic focus. This suggests common immunological fea-
tures in the retina and the epileptic focus.
Although the retina exhibited a pronounced glial reac-
tion, retinal neurodegeneration was subtle compared to
the pathology within the epileptic focus [5, 17, 19, 23].
We found no evidence for prominent retinal neuronal
death in terms of disseminated retinal lamination, in-
creased numbers of pyknotic cells, or Fluoro-Jade-positive
cells at the time points studied. Still, the increased number
of activated microglia, often in clusters, disarranged the
normally very strict territorial distribution of the retinal
microglia [29], and is most likely reflecting alterations in
their normal function as regulators of synaptogenesis and
synaptic transmission [30, 31]. Similarly, the decreased
levels of the excitatory synaptic scaffolding protein PSD-
95 in the ONL, where we observed seizure-induced aber-
rant microglia processes, may indicate a homeostatic im-
balance in excitatory transmission. The technique for
intensity measurements was not sensitive enough for de-
tecting minor differences in high intensity regions, which
may explain why we did not detect changes in synaptic
plexiform layers with strong PSD-95 expression [32]. Fu-
ture electrophysiological recordings of retinal neuronal
networks will be important for validating synaptic trans-
mission and functional deficiencies.
Interestingly, other neurological diseases have also re-
cently been described to induce retinal inflammation but
Fig. 7 Reduced PSD-95 expression after temporal SE. Representative confocal photomicrographs of PSD-95 scaffolding protein clusters (arrow heads in
inset) in the retina of NSC (a) and 7 weeks post-SE (b). Quantification of intensity measurements relative to NSC of PSD-95 clusters in ONL of ipsi- and
contralateral retina 7 weeks post-SE compared to NSC showed reduced levels after SE in the ipsilateral retina (c). Data are presented as means ± SEM,
n = 9 NSC and n = 6 SE group. *p≤ 0.05 un-paired t test compared to controls. Scale bars are 50 μm for (a) and (b), and 5 μm in inset
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with more pronounced neurodegeneration. In experimental
and clinical studies on stroke, Parkinson’s, Huntingtons’,
and Alzheimer’s diseases, reduced retinal ganglion cell
numbers, and nerve fiber layer thinning are evident, caus-
ing visual disturbances [33]. Activation of micro- and
macroglia, mononuclear infiltrations, and microvascular ab-
normalities have also been reported [33–39]. In addition,
demyelinating diseases like multiple sclerosis show optic
disc and nerve dysfunction [33]. Notably, experimental AD
studies linked increased retinal glial activation to astrocyte
changes in the brain [37]. However, since the presented
delayed upregulation of GFAP in macroglia after SE is an
early indicator of reactive gliosis [40], we cannot rule out
that the pathology may progress beyond 7 weeks post-SE
Fig. 8 Decreased seizure-induced glial activation in the retina after CX3CR1 antibody treatment. Representative photomicrographs of the retina
7 weeks after SE (a) and CX3CR1 antibody-treated SE (b). Arrow heads depict Iba1+ cells in the IPL and OPL. Quantification of numbers of Iba1+cells in
the ipsi- and contralateral retina at 7 weeks revealed a decrease after CX3CR1 treatment (c). Quantification of the relative percentage of
microglia with different morphologies at 7 weeks showed a relative increase in ramified and a reduction in intermediate and amoeboid
morphologies (d). Representative images of GFAP expression in macroglia in the retina 7 weeks post-SE (e) and post-SE with CX3CR1-treatment (f).
GFAP+ processes in the IPL are marked with arrow heads in (e). Quantification of GFAP+ Müller cell processes in the IPL showed reduced numbers after
SE (g). Data are presented as means ± SEM in (c) and (d), and as median range with upper quartile range in (g), n = 6 SE and n = 7 CX3CR1-
treated SE group. *p ≤ 0.05 un-paired t test in (c), 2-way ANOVA in (d), Mann-Whitney’s rank sum test in (g). †p = 0.067 in (c). Scale bars are
500 μm for (a) and (b), and 50 μm for (e) and (f)
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and with additional seizures. Conversely, since there was a
high variation in retinal GFAP expression within both the
SE and NSC group 6 h and 1 week after SE, we cannot
rule out that there may be changes occurring acutely that
were not detected with our analyses. The significance of
the small decrease in GFAP at 6 h after SE also remains to
be clarified.
Another important distinction between the current
and previous studies on stroke and neurodegenerative
diseases is the fact that the temporal seizures were initi-
ated from implanted electrodes within a very localized
area of an initially healthy brain, without genetic suscep-
tibility or systemic immunological/vascular deficiencies.
Hence, the retinal changes could only have occurred as a
result of the SE insult, the SE-induced spontaneous sei-
zures, and/or SE-induced epileptogenesis and not due to
an underlying disease, which is otherwise often the case
in epilepsy. Future correlation studies of seizure num-
bers and degree of retinal inflammation as well as stud-
ies on retinal inflammation in other models of epilepsy
may give more answers to what extent retinal inflamma-
tion is a biomarker of epileptogenesis or merely a reac-
tion to seizures per se.
There are at least four possible scenarios that may ex-
plain the underlying mechanisms of the seizure-induced
retinal immune response. First, temporal seizures initiate
an acute systemic immune response which may spread
through the BRB. Common inflammatory mediators are
upregulated in both the hippocampus and enthorinal
cortex 24 h after SE [41]. However, when evaluating the
same immune factors at an earlier time point in eye ho-
mogenates, no such increase was found. Instead, subtle
changes in cytokine/chemokine levels were observed
with a delay. A systemic immune response may also trig-
ger a delayed infiltration of leukocytes from the retinal
vessels in the subretinal or retinal layers. Though, we did
not observe such an adaptive response, it may still occur
at other time points. We also did not find changes in
numbers of vascular pericytes, as in, i.e., diabetic retinop-
athy [42, 43]. Vascular pericytes are situated along endo-
thelial cells in the wall of small blood vessels [44, 45] and
sense microvascular dysfunction [46, 47]. Here, we cannot
rule out that seizures lead to altered BRB function and a
more subtle microvascular reorganization. Moreover,
there are studies describing retinal microglial activation
without prominent infiltrating leukocytes during a sys-
temic inflammation and viral infections [14].
Secondly, the seizures may change the intracranial pres-
sure (ICP) and influence the intraocular pressure (IOP)
within the eyes. An imbalance between the anterior IOP
and posterior ICP fluid pressures on the optic nerve may
lead to abnormal function and nerve damage in GCL and
ONL due to changes in axonal transport or altered blood
flow, as seen in glaucoma [48, 49]. Initial signs of
increased IOP may include altered PSD-95 expression and
gliosis [50, 51].
Thirdly, the immune response in the epileptic focus
may spread to other brain areas involved in the temporal
seizure networks, including subcortical structures, and
via the visual pathways initiate changes as far as the ret-
ina. It is likely that such a scenario would induce a
stronger immune response close to the entrance of the
optic nerve and inner part of the retina. Accordingly, we
found macroglia activation primarily in the inner retina.
However, the microglial cells did not gather within the
inner layers but were evenly distributed within synaptic
layers and aberrantly in the ONL. Detailed investigations
of the nerve fiber tract and optic disc may reveal more
subtle local changes in favor of a direct rostral cerebrum-
to-retina signaling. In support, studies in AD patients sug-
gest that inflammation may, through soluble pathogenic
factors such as small nucleic acids, spread from the limbic
structures both into the visual cortex, optic nerve, and the
retina [39, 52].
Fourthly, an epileptic seizure may induce a retrograde
current through the optic nerve, initiating an imbalance
in excitatory/inhibitory transmission in the retinal net-
work and thereby a glial activation. Whether the retinal
neurons may have the properties to exhibit abnormal
synchronized firing similar to a seizure among cortical
neurons is to our knowledge not known. Activated
Müller cell processes in the inner retina may perhaps
contribute to epileptic discharges, as suggested for astro-
cytes in the rest of the brain [10].
The seizure-induced glial activation was evident in the
retina both ipsi- and contralateral to the temporal epileptic
focus. A previous case report on Rasmussen’s encephalitis,
a severe inflammatory epileptic encephalopathy engaging
only one brain hemisphere, described an ipsilateral ocular
inflammation in the patient [53]. The authors speculated
to what extent an immune reaction in the eye after focal
seizures may also be associated with clinical manifesta-
tions. However, apart from small alterations in cytokine/
chemokine levels in the ipsilateral retina only, we could
not find significant differences between the two retinas
after focal temporal seizures helping in determining
whether the rat exhibited left or right temporal lobe
seizures. In the current study, we did not differentiate be-
tween lateral and medial parts of the retina; and therefore,
we cannot define whether the retinal inflammation may be
correlated to the left or right hemisphere-innervated visual
field. This will be important to analyze in future studies.
A reduced glial activation both in the retina and within
epileptic foci following intracerebroventricular CX3CR1
Ab treatment suggests that the two immune responses,
despite being remotely located, share similar activated
signaling pathways. The fractalkine-CX3CR1 pathway is
involved in the activation and migration of immune
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cells [27, 54, 55], and an increased expression of
CX3CR1 in the epileptic focus suggests a dysfunctional
neuron-glial cross talk [19, 56, 57]. Thus, a reduced im-
mune response in the eye after CX3CR1 Ab treatment
may be due to a reduced propagation of the immune
response from the epileptic focus/network, which could
be a result of both a reduced microglia activation and
neurodegeneration within the epileptic focus and a dir-
ect inhibition of the migratory capacity of the immune
cells. However, CX3CR1 deficiency has been associated
with eye-related disorders [58–60]; thus, we do not
know the functional consequences of inhibiting seizure-
induced retinal immune response with CX3CR1 Ab.
During healthy conditions, the glial cells are important
for keeping the homeostasis. The seizure-induced ret-
inal immune response or the remaining immune response
after CX3CR1 Ab treatment may be dysfunctional. As for
the immune response in the rest of the brain, the retinal
immune response is likely to both contribute to and re-
store pathology [61]. However, we believe that the mere
existence of a retinal glial activation may turn out to be
a potential novel biomarker of seizure-induced or
epileptogenesis-associated brain inflammation. The fact
that the retina is more accessible than many other parts
of the brain makes it more attractive for diagnostic
purposes. Studying the immune reaction in the eyes of
epilepsy patients and correlating it to the seizure semi-
ology, development, and prognosis may turn out to be
clinically relevant.
To what extent a visual dysfunction in patients with
temporal epilepsy exists and correlates to a glial activa-
tion in the retina and brain remains to be shown. Pa-
tients with epilepsy do not commonly describe visual
disturbances, except for those with visual cortical in-
volvements or drug-induced side effects. Therefore, we
do not currently know if patients have retinal inflamma-
tion and visual disturbances subclinically. In the present
study, we have also not addressed the question as to
what extent rodents with temporal epileptic seizures
suffer from functional retinal deficiencies. Future studies
with pattern evoked electroretinography and multi-
electrode array analysis of retinal physiology will be highly
relevant [62, 63].
Conclusions
These are the first evidence that epileptic seizures lead
to an immune response in the retina. The finding has a
potential to become a novel non-invasive tool for detect-
ing brain inflammation through the eyes.
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